logo
15:59 Dec 05

Sector Industry
Up
933.60
-15.65 (-1.65%)
Sector Industry

Natco Pharma Ltd. Financials

Natco Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
933.60
-15.65 (-1.65%)
15:59 Dec 05
Quality
image/svg+xml

64/100
High Financial Strength

Valuation
image/svg+xml

45/100
Mid Valuation

Technical

55/100
Technically Neutral

Strength

15

Weakness

6

Opportunity

0

Threats

0

24.78 %

ROE %

21.84 %

ROA %

85.91

EPS

424.97

BVPS

42.56 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1944.8 2707.1 3998.8 4429.5 4387.7
Operating Expenses +
1681.3 1771.5 2247.4 2233.5 2650.6
Raw Material
577.7 651 673.9 702.3 787
Increase Decrease in Cost
-16.8 -23.7 42.7 -12.5 -52.3
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
444.8 486.7 525 594.5 670.3
Miscellaneous Expenses
792.6 1008.9 1308.6 1281.4 1245.6
Operating Profit
263.5 935.6 1751.4 2196 1737.1
Other Income
99 104.6 128.1 354.5 404.3
Depreciation
142.6 163.8 186.8 235.2 255.3
Interest
17.7 14.5 19.2 23.9 30.9
Profit before tax and exceptio..
202.2 861.9 1673.5 2291.4 1855.2
Exceptional Items
0 0 0 0 0
PBT
202.2 861.9 1673.5 2291.4 1855.2
Provision for Taxation
32.2 146.6 285.2 408 318.6
Net Profit
170 715.3 1388.3 1883.4 1536.6
NET Profit after MI
170 715.3 1388.3 1885.4 1538.7
EPS
9.32 39.18 77.34 105.26 85.91
Operating Profit Margin (%)
13.55 34.56 43.8 49.58 39.59
Net Profit Margin (%)
8.74 26.42 34.72 42.56 35.07

Natco Pharma Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 49.50 49.60 49.60 49.60 49.60 49.70
FII 14.10 15.50 17.50 17.90 17.50 17.40
Public 5.90 5.80 5.60 5.60 6.80 7.90
Others 30.50 29.10 27.30 26.90 26.10 25.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: